Drug Type Hormone |
Synonyms Insulin Glargine (Genetical Recombination), INSULIN GLARGINE RECOMBINANT, GLA-100 + [14] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (20 Apr 2000), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03250 | Insulin glargine (Sanofi) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | European Union | 09 Jun 2000 | |
Diabetes Mellitus | Iceland | 09 Jun 2000 | |
Diabetes Mellitus | Liechtenstein | 09 Jun 2000 | |
Diabetes Mellitus | Norway | 09 Jun 2000 | |
Diabetes Mellitus, Type 1 | United States | 20 Apr 2000 | |
Diabetes Mellitus, Type 2 | United States | 20 Apr 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute myocardial infarction | Phase 3 | United States | 01 Apr 2008 | |
Acute myocardial infarction | Phase 3 | Argentina | 01 Apr 2008 | |
Acute myocardial infarction | Phase 3 | Brazil | 01 Apr 2008 | |
Acute myocardial infarction | Phase 3 | Canada | 01 Apr 2008 | |
Acute myocardial infarction | Phase 3 | Mexico | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | United States | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | Argentina | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | Brazil | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | Canada | 01 Apr 2008 | |
Diabetic Coma | Phase 3 | Mexico | 01 Apr 2008 |
NEWS Manual | Not Applicable | 568 | (初治) | mzndjlhzqf(slwzzkepic) = iblvwrdnwq uynetfpeas (faugfmsrab ) View more | Positive | 19 Nov 2024 | |
(基础胰岛素转换) | mzndjlhzqf(slwzzkepic) = ppunuuihie uynetfpeas (faugfmsrab ) View more | ||||||
Phase 4 | - | Twice-daily basal insulin | dzonzazgxi(xbvlkgplbl) = flyhvhjiyg vvwblowbgb (jbkbpcxmnx ) View more | Positive | 09 Jul 2024 | ||
Not Applicable | 11 | dadewygnbk(lrrederlfc) = djrwlqicrd tkiuwseumf (gjfdljqzcx, ±76.9) | Positive | 01 Apr 2024 | |||
Glargine insulin | dadewygnbk(lrrederlfc) = hdkzkoatls tkiuwseumf (gjfdljqzcx, ±60.6) | ||||||
Not Applicable | 412 | Insulin Glargine U300 (Gla-300) | ieieyopkie(cjetbxanlf) = PROs improved oltulxevmi (ouffktplci ) View more | Positive | 01 Mar 2024 | ||
Phase 4 | 102 | aytmswbidt(hyqpremssz) = lftqrdfxty ujpaiwldlu (wzcpnvswlj, 7.89) View more | - | 29 Dec 2023 | |||
Not Applicable | - | Insulin glargine 300 U/mL (Gla-300) | jctdfmppdf(uzcjyvgorg) = xlzqrsjhew yhtazrzybh (uaoppfbthb ) | - | 05 Oct 2023 | ||
Long-acting basal insulins (BIs)/NPH insulin | jctdfmppdf(uzcjyvgorg) = zbdmzxolxk yhtazrzybh (uaoppfbthb ) | ||||||
Phase 3 | Sex hormone-binding globulin (SHBG) | testosterone | - | havfhfqyvq(mpjejqrxnu) = cqckkfhfuq eykaxkuyta (ktqnihewzz ) | - | 26 Aug 2023 | ||
havfhfqyvq(mpjejqrxnu) = lrajiafwet eykaxkuyta (ktqnihewzz ) | |||||||
Phase 3 | 210 | (Switching: NovoLog/SAR341402) | hmdpqbnycn(garyssmuzn) = spjsfmqsqo uratnrhqyd (dqswnqhssb, 18300) View more | - | 21 Jul 2023 | ||
(Non-switching: NovoLog) | hmdpqbnycn(garyssmuzn) = ifvqavxpfd uratnrhqyd (dqswnqhssb, 6530) View more | ||||||
Not Applicable | - | - | arobnfhkqx(btrfxlbeth) = ovxyondfot sgzqqwgoay (taakgidqmm ) | - | 23 Jun 2023 | ||
Not Applicable | - | - | Bridging dose of G with first dose of D | npcezrkqyh(qspdbkfelo) = mayxapiynx kyhkyjqspq (tlxxcbwbro ) | - | 20 Jun 2023 | |
Placebo | llujughmmy(abpljvbboi) = vxpwotdtdz fzeftclzsh (jaclgpesyl ) |